Glycerol Fructose Injection
Function and Efficacy
This product enters the whole body tissues through the blood, and its distribution reaches equilibrium in about 2-3 hours. It enters the cerebrospinal fluid and brain tissue slowly, and is also slowly cleared. Most of this product is metabolized into CO2 and water.
Ingredients
This product is a compound preparation, containing 10g glycerol, 5g fructose and 0.9g sodium chloride per 100ml.
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| GlycerolIngredients |
This product enters the whole body tissues through the blood, and its distribution reaches equilibrium in about 2-3 hours. It enters the cerebrospinal fluid and brain tissue slowly, and is also slowly cleared. Most of this product is metabolized into CO2 and water. More |
56-81-5 | 61 | |
| beta-D-FructopyranoseIngredients |
This product enters the whole body tissues through the blood, and its distribution reaches equilibrium in about 2-3 hours. It enters the cerebrospinal fluid and brain tissue slowly, and is also slowly cleared. Most of this product is metabolized into CO2 and water. More |
7660-25-5 | 14 | |
| Sodium chlorideIngredients |
This product enters the whole body tissues through the blood, and its distribution reaches equilibrium in about 2-3 hours. It enters the cerebrospinal fluid and brain tissue slowly, and is also slowly cleared. Most of this product is metabolized into CO2 and water. More |
7647-14-5 | 43 |
Indication
It is used for symptoms such as acute and chronic increased intracranial pressure and cerebral edema caused by cerebrovascular disease, brain trauma, brain tumors, intracranial inflammation and other reasons.
Usage and Dosage
For intravenous drip, adults usually take 250-500ml at a time, 1-2 times a day, 500ml for 2-3 hours, 250ml for 1-1.5 hours. The dosage can be increased or decreased according to age and symptoms.
Adverse Reactions
1. Acidosis (incidence unknown): Lactic acidosis may occur and sodium bicarbonate injection should be given.
Precautions
1. Patients with hereditary fructose intolerance are prohibited from using this product. 2. Patients who are allergic to any component of this product. 3. Patients with hypernatremia, anuria and severe dehydration.
Special Population Medication
Precautions for children: Not yet clear. Precautions for pregnancy and lactation: Not yet clear. Precautions for the elderly: Not yet clear.
Drug Interactions
Not yet clear.
Storage
Sealed storage
Packaging Specification
250ml
Manufacturer
Foshan Haolang Pharmaceutical Co., Ltd.
-
Founded in:
1995-01-10 -
Address:
Hecun Development Zone, Lishui Town, Nanhai District, Foshan City -
Tax NO.:
91440605280031572M -
Registered Funds:
30 million yuan -
Email: